|
|
Volumn 19, Issue 10, 2012, Pages 1213-1214
|
|
Revisiting the specificity of small molecule inhibitors: The example of stattic in dendritic cells
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
DENDRITIC CELL VACCINE;
INTERLEUKIN 12;
INTERLEUKIN 6;
PROTEIN INHIBITOR;
STAT1 PROTEIN;
STAT2 PROTEIN;
STAT3 PROTEIN;
STATTIC;
UNCLASSIFIED DRUG;
CANCER CELL;
CANCER GROWTH;
CANCER IMMUNOTHERAPY;
CELLULAR IMMUNITY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DENDRITIC CELL;
DRUG TARGETING;
ENZYME ACTIVITY;
HUMAN;
LETTER;
MICHAEL ADDITION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
RNA INTERFERENCE;
SIGNAL TRANSDUCTION;
TH1 CELL;
TREATMENT RESPONSE;
TUMOR MICROENVIRONMENT;
CYCLIC S-OXIDES;
HUMANS;
STAT3 TRANSCRIPTION FACTOR;
|
|
EID: 84868036296
PISSN: 10745521
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chembiol.2012.08.021 Document Type: Letter |
|
Times cited : (26)
|
|
References (7)
|
